Biotricity Q1 FY27 net loss widens 42.8% to $959,468; revenue rises 10.4% to $4.28 million

Reuters2026/08/19 20:07

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Biotricity posted a GAAP net loss of $959,468 for the quarter ended June 30, 2026, widening from the prior-year quarter.
Revenue rose 10.4% to $4.28 million, driven by a 23.6% increase in recurring technology fee revenue to $4.2 million.
Operating income fell 43.9% to $158,068 as selling, general and administrative expense climbed 26.2% to $2.7 million.
Gross margin improved 2.1 percentage points to 82.6%; technology fees made up 97.4% of revenue.
Non-GAAP adjusted EBITDA increased to $499,526; GAAP EBITDA eased to $90,409 on higher share-based compensation.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biotricity Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-039209), on August 19, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Biotricity Q1 FY27 net loss widens 42.8% to $959,468; revenue rises 10.4% to $4.28 million

You may also like

Crypto prices